New Resources Help Canadians Tackle Retirement Preparedness
Ottawa, Ontario--(Newsfile Corp. - February 12, 2025) - More than half of Canadians lack a comprehensive retirement plan, and of...
Disability
Anaptys Announces Rosnilimab Achieved Positive Results in RA Phase 2b Trial and Highest Ever Reported CDAI LDA Response Over 6 Months
Achieved statistical significance on primary endpoint at Week 12 on mean change from baseline DAS-28 CRP across all rosnilimab doses...
MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers
Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim...
Alterity Therapeutics Raises A$40.0 million in Placement
– Funds to be used primarily to advance development of ATH434 in Parkinsonian Disorders – – Capital raising was strongly...
BRTX-100 Front and Center at ORS 2025
– New blinded preliminary BRTX-100 data described this past Saturday at prestigious “2025 Winners in Industry Innovations in MSK Health”...
Nicolas S. Piuzzi, MD, Presented Kappa Delta Young Investigator Award for Research on Employing Data Analytics to Improve Patient Outcomes
ROSEMONT, Ill., Feb. 7, 2025 /PRNewswire/ -- Nicolas S. Piuzzi, MD, was recognized as the 2025 Kappa Delta Young Investigator Award...
Veru to Report Fiscal 2025 First Quarter Financial Results on February 13, 2025
MIAMI, FL, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
Veru to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
MIAMI, FL, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader
NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era...
2025 Therap National Conference Day Two: Key Session by Justin Brockie on Therap in the Age of Artificial Intelligence
TORRINGTON, Conn., Jan. 29, 2025 /PRNewswire/ -- Therap Services, the premier provider of HIPAA-compliant electronic documentation solutions for organizations and...
JOSHIN AND INTEGRATE AUTISM EMPLOYMENT ADVISORS ANNOUNCE PARTNERSHIP TO BRING HOLISTIC NEURODIVERSITY SUPPORT SERVICES TO EMPLOYERS
MINNEAPOLIS, Jan. 29, 2025 /PRNewswire/ -- Joshin, a leading provider of neurodivergent and disability support services, and Integrate Autism Employment...
Brain Aneurysm Foundation’s Executive Director Christine Buckley to Speak at the 2025 International Stroke Conference
HANOVER, Mass., Jan. 29, 2025 /PRNewswire/ -- The Brain Aneurysm Foundation (BAF), the leading advocacy organization supporting education, research, and policy to...
Ambulatory Care Nurses Week: A Nationwide Tribute to Nursing Excellence
PITMAN, N.J., Jan. 28, 2025 /PRNewswire/ -- The American Academy of Ambulatory Care Nursing (AAACN) invites nurses, health care organizations, and communities...
Sera Prognostics to Host Virtual R&D Day on January 31
Event will showcase results of Company's pivotal PRIME study and include the principal investigator SALT LAKE CITY, Jan. 27, 2025...
CTA FOUNDATION CELEBRATES AN INCREDIBLE CES 2025, HIGHLIGHTING ACCESSIBILITY INNOVATION AND COLLABORATION
LAS VEGAS, Jan. 21, 2025 /PRNewswire/ -- The Consumer Technology Association (CTA)® Foundation wrapped up an exciting and impactful week at...
Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target
--128 enrolled participants, as of December 31, 2024, exceeds initial target of 90 participants-- --150 maximum participant enrollment projected by...
JOSHIN AND AON COLLABORATE TO OFFER SPECIALIZED NEURODIVERSITY SUPPORT SERVICES TO EMPLOYERS
Collaboration delivers strategic Neurodiversity initiatives, with comprehensive support and advanced analytics and insights tailored to both individual and organizational needs....
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present January 12 at the Annual Neuroscience Innovation Forum
Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription...
Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a...
Veterans Benefits Administration awards medical disability examination services contract to Leidos QTC Health Services
RESTON, Va., Jan. 6, 2025 /PRNewswire/ -- Leidos (NYSE:LDOS) today announced that its wholly owned subsidiary, QTC Medical Services, operating under the...